| Mr Donnie L Mcmickle, MD | |
|
777 Hemlock St, Macon, GA 31201-2102 | |
| (866) 507-5244 | |
| (855) 851-4405 |
| Full Name | Mr Donnie L Mcmickle |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 31 Years |
| Location | 777 Hemlock St, Macon, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306881438 | NPI | - | NPPES |
| 000743168C | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 039176 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Phoebe Putney Memorial Hospital | Albany, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoebe Physician Group Inc | 8426112350 | 342 |
News Archive
"The World Intellectual Property Organization, in conjunction with the World Health Organization, private sector and foundation partners, is preparing to launch a new voluntary database for the sharing of intellectual property for research and development on medicines, vaccines and diagnostics for neglected diseases, according to sources in Geneva," Intellectual Property Watch reports.
Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts.
In collaboration with the International EMF Alliance (IEMFA), scientists from Europe, North America, Australia and Israel have sent an Open Letter to Dr. Christopher Wild, Director of the International Agency for Research on Cancer (IARC), calling for a postponement of the forthcoming meeting May 24-31, 2011 in Lyon, France, "Non-Ionizing Radiation, Part II: Radiofrequency Electromagnetic Field [includes mobile telephones]," at which determination of the carcinogenicity of cell phones and wireless technologies will be made.
ProteoTech, Inc., a privately held biotechnology company, has entered into a drug development agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTech's small molecule technology platform against misfolded proteins to specifically advance work on its alpha-synuclein therapeutic program for the treatment of Parkinson's disease and other synucleinopathies.
MacroGenics, Inc., a privately held biotechnology company that develops next generation antibody therapeutics, announced today that it will receive a milestone payment from Boehringer Ingelheim.
› Verified 9 days ago
| Entity Name | Phoebe Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487899464 PECOS PAC ID: 8426112350 Enrollment ID: O20090121000583 |
News Archive
"The World Intellectual Property Organization, in conjunction with the World Health Organization, private sector and foundation partners, is preparing to launch a new voluntary database for the sharing of intellectual property for research and development on medicines, vaccines and diagnostics for neglected diseases, according to sources in Geneva," Intellectual Property Watch reports.
Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts.
In collaboration with the International EMF Alliance (IEMFA), scientists from Europe, North America, Australia and Israel have sent an Open Letter to Dr. Christopher Wild, Director of the International Agency for Research on Cancer (IARC), calling for a postponement of the forthcoming meeting May 24-31, 2011 in Lyon, France, "Non-Ionizing Radiation, Part II: Radiofrequency Electromagnetic Field [includes mobile telephones]," at which determination of the carcinogenicity of cell phones and wireless technologies will be made.
ProteoTech, Inc., a privately held biotechnology company, has entered into a drug development agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTech's small molecule technology platform against misfolded proteins to specifically advance work on its alpha-synuclein therapeutic program for the treatment of Parkinson's disease and other synucleinopathies.
MacroGenics, Inc., a privately held biotechnology company that develops next generation antibody therapeutics, announced today that it will receive a milestone payment from Boehringer Ingelheim.
› Verified 9 days ago
| Entity Name | Guardian Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255786521 PECOS PAC ID: 8325347735 Enrollment ID: O20160505001064 |
News Archive
"The World Intellectual Property Organization, in conjunction with the World Health Organization, private sector and foundation partners, is preparing to launch a new voluntary database for the sharing of intellectual property for research and development on medicines, vaccines and diagnostics for neglected diseases, according to sources in Geneva," Intellectual Property Watch reports.
Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts.
In collaboration with the International EMF Alliance (IEMFA), scientists from Europe, North America, Australia and Israel have sent an Open Letter to Dr. Christopher Wild, Director of the International Agency for Research on Cancer (IARC), calling for a postponement of the forthcoming meeting May 24-31, 2011 in Lyon, France, "Non-Ionizing Radiation, Part II: Radiofrequency Electromagnetic Field [includes mobile telephones]," at which determination of the carcinogenicity of cell phones and wireless technologies will be made.
ProteoTech, Inc., a privately held biotechnology company, has entered into a drug development agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTech's small molecule technology platform against misfolded proteins to specifically advance work on its alpha-synuclein therapeutic program for the treatment of Parkinson's disease and other synucleinopathies.
MacroGenics, Inc., a privately held biotechnology company that develops next generation antibody therapeutics, announced today that it will receive a milestone payment from Boehringer Ingelheim.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Donnie L Mcmickle, MD Po Box 551420, Fort Lauderdale, FL 33355-1420 Ph: (800) 243-3839 | Mr Donnie L Mcmickle, MD 777 Hemlock St, Macon, GA 31201-2102 Ph: (866) 507-5244 |
News Archive
"The World Intellectual Property Organization, in conjunction with the World Health Organization, private sector and foundation partners, is preparing to launch a new voluntary database for the sharing of intellectual property for research and development on medicines, vaccines and diagnostics for neglected diseases, according to sources in Geneva," Intellectual Property Watch reports.
Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts.
In collaboration with the International EMF Alliance (IEMFA), scientists from Europe, North America, Australia and Israel have sent an Open Letter to Dr. Christopher Wild, Director of the International Agency for Research on Cancer (IARC), calling for a postponement of the forthcoming meeting May 24-31, 2011 in Lyon, France, "Non-Ionizing Radiation, Part II: Radiofrequency Electromagnetic Field [includes mobile telephones]," at which determination of the carcinogenicity of cell phones and wireless technologies will be made.
ProteoTech, Inc., a privately held biotechnology company, has entered into a drug development agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTech's small molecule technology platform against misfolded proteins to specifically advance work on its alpha-synuclein therapeutic program for the treatment of Parkinson's disease and other synucleinopathies.
MacroGenics, Inc., a privately held biotechnology company that develops next generation antibody therapeutics, announced today that it will receive a milestone payment from Boehringer Ingelheim.
› Verified 9 days ago
Dr. Mauro Faibicher, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hemlock St, Macon, GA 31201 Phone: 866-507-5244 Fax: 855-851-4405 | |
Keith N Phillippi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 380 Hospital Drive, Suite 410, Macon, GA 31217 Phone: 478-746-5644 Fax: 478-745-4849 | |
Dr. David M Kalish Iii, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hemlock St, Macon, GA 31201 Phone: 866-507-5244 Fax: 855-851-4405 | |
Hubert R Buxton Iii, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 380 Hospital Drive, Suite 410, Macon, GA 31217 Phone: 478-746-5644 Fax: 478-745-4849 | |
Manojna P Sanjeev, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 380 Hospital Drive, Suite 410, Macon, GA 31217 Phone: 478-746-5644 Fax: 478-745-4849 | |
Boris Pechenik, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 777 Hemlock St, Macon, GA 31201 Phone: 478-633-1000 | |
Pravin K Jain, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 380 Hospital Drive, Suite 410, Macon, GA 31217 Phone: 478-746-5644 Fax: 478-745-4849 |